Biomedical Science

9.

Integrative and Applied Biomedical Science

9.1.

Bioinformatics and Computational Biology

9.1.1.

Introduction to Bioinformatics

9.1.1.1.

Definition and Scope

9.1.1.2.

Applications in Biomedical Research

9.1.1.3.

Computational Tools and Resources

9.1.2.

Biological Databases

9.1.2.1.

Sequence Databases

9.1.2.1.1.

9.1.2.1.2.

9.1.2.1.3.

9.1.2.2.

Protein Databases

9.1.2.2.1.

9.1.2.2.2.

Protein Data Bank

9.1.2.2.3.

9.1.2.3.

Genomic Databases

9.1.2.3.1.

9.1.2.3.2.

UCSC Genome Browser

9.1.2.3.3.

9.1.2.4.

Literature Databases

9.1.2.4.1.

9.1.2.4.2.

Bioinformatics Literature

9.1.3.

Sequence Analysis

9.1.3.1.

Sequence Alignment

9.1.3.1.1.

Pairwise Alignment

9.1.3.1.1.1.

Global Alignment

9.1.3.1.1.2.

Local Alignment

9.1.3.1.1.3.

Scoring Matrices

9.1.3.1.2.

Multiple Sequence Alignment

9.1.3.1.2.1.

Progressive Alignment

9.1.3.1.2.2.

Iterative Methods

9.1.3.2.

Database Searching

9.1.3.2.1.

9.1.3.2.2.

9.1.3.2.3.

Profile-Based Searches

9.1.3.3.

Phylogenetic Analysis

9.1.3.3.1.

Tree Construction Methods

9.1.3.3.2.

Molecular Evolution

9.1.3.3.3.

Species Relationships

9.1.4.

9.1.4.1.

Genome Sequencing

9.1.4.1.1.

Whole Genome Sequencing

9.1.4.1.2.

Genome Assembly

9.1.4.1.3.

Genome Annotation

9.1.4.2.

Comparative Genomics

9.1.4.2.1.

Synteny Analysis

9.1.4.2.2.

Ortholog Identification

9.1.4.2.3.

Evolutionary Genomics

9.1.4.3.

Functional Genomics

9.1.4.3.1.

Gene Expression Analysis

9.1.4.3.2.

Regulatory Element Prediction

9.1.4.3.3.

Pathway Analysis

9.1.5.

9.1.5.1.

Protein Structure Analysis

9.1.5.1.1.

Secondary Structure Prediction

9.1.5.1.2.

Tertiary Structure Modeling

9.1.5.1.3.

Protein Folding

9.1.5.2.

Protein Function Prediction

9.1.5.2.1.

Domain Analysis

9.1.5.2.2.

Functional Annotation

9.1.5.2.3.

Protein-Protein Interactions

9.1.5.3.

Mass Spectrometry Data Analysis

9.1.5.3.1.

Peptide Identification

9.1.5.3.2.

Protein Quantification

9.1.5.3.3.

Post-Translational Modifications

9.1.6.

Transcriptomics

9.1.6.1.

RNA-Seq Analysis

9.1.6.1.1.

9.1.6.1.2.

Transcript Assembly

9.1.6.1.3.

Differential Expression Analysis

9.1.6.2.

Single-Cell RNA Sequencing

9.1.6.2.1.

Cell Type Identification

9.1.6.2.2.

Trajectory Analysis

9.1.6.2.3.

Spatial Transcriptomics

9.1.6.3.

Non-Coding RNA Analysis

9.1.6.3.1.

microRNA Target Prediction

9.1.6.3.2.

Long Non-Coding RNA Function

9.1.7.

Systems Biology

9.1.7.1.

Network Biology

9.1.7.1.1.

Protein Interaction Networks

9.1.7.1.2.

Gene Regulatory Networks

9.1.7.1.3.

Metabolic Networks

9.1.7.2.

Pathway Analysis

9.1.7.2.1.

Pathway Databases

9.1.7.2.2.

Enrichment Analysis

9.1.7.2.3.

Network-Based Analysis

9.1.7.3.

Mathematical Modeling

9.1.7.3.1.

Ordinary Differential Equations

9.1.7.3.2.

Boolean Networks

9.1.7.3.3.

Stochastic Models

9.1.8.

Structural Bioinformatics

9.1.8.1.

Protein Structure Databases

9.1.8.2.

Structure Prediction Methods

9.1.8.3.

Drug Design Applications

9.1.8.4.

Molecular Dynamics Simulations

9.1.9.

Clinical Bioinformatics

9.1.9.1.

Genomic Medicine

9.1.9.1.1.

Variant Annotation

9.1.9.1.2.

Clinical Interpretation

9.1.9.1.3.

Pharmacogenomics

9.1.9.2.

Precision Medicine

9.1.9.2.1.

Biomarker Discovery

9.1.9.2.2.

Treatment Selection

9.1.9.2.3.

Patient Stratification

9.2.

Epidemiology and Public Health

9.2.1.

Principles of Epidemiology

9.2.1.1.

Definition and Scope

9.2.1.2.

Epidemiological Triad

9.2.1.3.

Causation in Epidemiology

9.2.1.4.

Prevention Strategies

9.2.2.

9.2.2.1.

Descriptive Studies

9.2.2.1.1.

9.2.2.1.2.

9.2.2.1.3.

Cross-Sectional Studies

9.2.2.1.4.

Ecological Studies

9.2.2.2.

Analytical Studies

9.2.2.2.1.

Case-Control Studies

9.2.2.2.2.

9.2.2.2.3.

Nested Case-Control Studies

9.2.2.3.

Experimental Studies

9.2.2.3.1.

Randomized Controlled Trials

9.2.2.3.2.

Community Trials

9.2.2.3.3.

Natural Experiments

9.2.3.

Measures of Disease Frequency

9.2.3.1.

9.2.3.1.1.

9.2.3.1.2.

Cumulative Incidence

9.2.3.1.3.

9.2.3.2.

9.2.3.2.1.

Point Prevalence

9.2.3.2.2.

Period Prevalence

9.2.3.3.

Mortality Measures

9.2.3.3.1.

Crude Mortality Rate

9.2.3.3.2.

Age-Specific Mortality Rate

9.2.3.3.3.

Case Fatality Rate

9.2.4.

Measures of Association

9.2.4.1.

9.2.4.2.

9.2.4.3.

Attributable Risk

9.2.4.4.

Population Attributable Risk

9.2.5.

Bias and Confounding

9.2.5.1.

9.2.5.2.

Information Bias

9.2.5.3.

Confounding Variables

9.2.5.4.

Effect Modification

9.2.6.

Screening and Diagnostic Tests

9.2.6.1.

Sensitivity and Specificity

9.2.6.2.

Predictive Values

9.2.6.3.

9.2.6.4.

Screening Programs

9.2.7.

Outbreak Investigation

9.2.7.1.

Outbreak Detection

9.2.7.2.

Descriptive Analysis

9.2.7.3.

Hypothesis Generation

9.2.7.4.

Analytical Studies

9.2.7.5.

Control Measures

9.2.8.

9.2.8.1.

Descriptive Statistics

9.2.8.1.1.

Measures of Central Tendency

9.2.8.1.2.

Measures of Variability

9.2.8.1.3.

Data Visualization

9.2.8.2.

Probability Distributions

9.2.8.2.1.

Normal Distribution

9.2.8.2.2.

Binomial Distribution

9.2.8.2.3.

Poisson Distribution

9.2.8.3.

Hypothesis Testing

9.2.8.3.1.

Type I and Type II Errors

9.2.8.3.2.

P-Values and Confidence Intervals

9.2.8.3.3.

9.2.8.4.

Statistical Tests

9.2.8.4.1.

9.2.8.4.2.

Chi-Square Tests

9.2.8.4.3.

9.2.8.4.4.

Regression Analysis

9.2.8.5.

Survival Analysis

9.2.8.5.1.

Kaplan-Meier Method

9.2.8.5.2.

Cox Proportional Hazards Model

9.2.9.

Environmental Health

9.2.9.1.

Environmental Risk Factors

9.2.9.2.

Exposure Assessment

9.2.9.3.

Dose-Response Relationships

9.2.9.4.

Risk Assessment

9.2.10.

Infectious Disease Epidemiology

9.2.10.1.

Transmission Dynamics

9.2.10.2.

9.2.10.3.

Vaccine Effectiveness

9.2.10.4.

Antimicrobial Resistance

9.2.11.

Chronic Disease Epidemiology

9.2.11.1.

Cardiovascular Disease

9.2.11.2.

Cancer Epidemiology

9.2.11.3.

9.2.11.4.

Respiratory Diseases

9.3.

Bioethics and Regulation

9.3.1.

Principles of Bioethics

9.3.1.1.

Historical Development

9.3.1.2.

Ethical Frameworks

9.3.1.3.

Principlism Approach

9.3.2.

Core Ethical Principles

9.3.2.1.

9.3.2.1.1.

Informed Consent

9.3.2.1.2.

Decision-Making Capacity

9.3.2.1.3.

Advance Directives

9.3.2.2.

9.3.2.2.1.

Duty to Do Good

9.3.2.2.2.

Risk-Benefit Analysis

9.3.2.2.3.

9.3.2.3.

Non-Maleficence

9.3.2.3.1.

9.3.2.3.2.

Risk Minimization

9.3.2.3.3.

Safety Considerations

9.3.2.4.

9.3.2.4.1.

Distributive Justice

9.3.2.4.2.

Procedural Justice

9.3.2.4.3.

9.3.3.

Research Ethics

9.3.3.1.

Historical Context

9.3.3.1.1.

9.3.3.1.2.

Declaration of Helsinki

9.3.3.1.3.

9.3.3.2.

Informed Consent in Research

9.3.3.2.1.

Elements of Informed Consent

9.3.3.2.2.

Vulnerable Populations

9.3.3.2.3.

Waiver of Consent

9.3.3.3.

Risk-Benefit Assessment

9.3.3.3.1.

9.3.3.3.2.

Risk Categories

9.3.3.3.3.

Risk Mitigation

9.3.4.

Human Subjects Protection

9.3.4.1.

Institutional Review Boards

9.3.4.1.1.

IRB Composition

9.3.4.1.2.

Review Procedures

9.3.4.1.3.

Continuing Review

9.3.4.2.

Vulnerable Populations

9.3.4.2.1.

9.3.4.2.2.

9.3.4.2.3.

9.3.4.2.4.

Cognitively Impaired Individuals

9.3.4.3.

International Research

9.3.4.3.1.

Cultural Considerations

9.3.4.3.2.

Resource-Limited Settings

9.3.4.3.3.

Collaborative Partnerships

9.3.5.

Animal Research Ethics

9.3.5.1.

Ethical Justification

9.3.5.2.

Three Rs Principle

9.3.5.2.1.

9.3.5.2.2.

9.3.5.2.3.

9.3.5.3.

Institutional Animal Care and Use Committees

9.3.5.4.

Animal Welfare Standards

9.3.6.

Clinical Ethics

9.3.6.1.

Patient-Physician Relationship

9.3.6.2.

9.3.6.3.

Confidentiality

9.3.6.4.

End-of-Life Care

9.3.6.5.

Resource Allocation

9.3.7.

Genetics and Genomics Ethics

9.3.7.1.

Genetic Testing

9.3.7.2.

Genetic Counseling

9.3.7.3.

Privacy and Discrimination

9.3.7.4.

9.3.7.5.

9.3.8.

Regulatory Framework

9.3.8.1.

Regulatory Agencies

9.3.8.1.1.

9.3.8.1.2.

9.3.8.1.3.

9.3.8.2.

Good Clinical Practice

9.3.8.2.1.

9.3.8.2.2.

Clinical Trial Conduct

9.3.8.2.3.

9.3.8.3.

Good Laboratory Practice

9.3.8.3.1.

9.3.8.3.2.

Quality Assurance

9.3.8.3.3.

Documentation Requirements

9.3.8.4.

Good Manufacturing Practice

9.3.8.4.1.

9.3.8.4.2.

Quality Control

9.3.8.4.3.

9.3.9.

Clinical Trial Regulations

9.3.9.1.

Protocol Development

9.3.9.2.

Investigational New Drug Applications

9.3.9.3.

Clinical Trial Phases

9.3.9.4.

Adverse Event Reporting

9.3.9.5.

Data Safety Monitoring

9.3.10.

Medical Device Regulation

9.3.10.1.

Device Classification

9.3.10.2.

Premarket Approval

9.3.10.3.

Quality System Regulation

9.3.10.4.

Post-Market Surveillance

9.3.11.

Intellectual Property

9.3.11.1.

Patents in Biotechnology

9.3.11.2.

9.3.11.3.

Technology Transfer

9.3.11.4.

Licensing Agreements

9.4.

Regenerative Medicine and Stem Cell Biology

9.4.1.

Introduction to Regenerative Medicine

9.4.1.1.

Definition and Goals

9.4.1.2.

Historical Perspective

9.4.1.3.

Current Applications

9.4.1.4.

Future Directions

9.4.2.

Stem Cell Biology

9.4.2.1.

Stem Cell Characteristics

9.4.2.1.1.

9.4.2.1.2.

9.4.2.1.3.

Differentiation Potential

9.4.2.2.

Types of Stem Cells

9.4.2.2.1.

Embryonic Stem Cells

9.4.2.2.1.1.

Derivation and Culture

9.4.2.2.1.2.

Pluripotency Markers

9.4.2.2.1.3.

Differentiation Protocols

9.4.2.2.2.

Adult Stem Cells

9.4.2.2.2.1.

Hematopoietic Stem Cells

9.4.2.2.2.2.

Mesenchymal Stem Cells

9.4.2.2.2.3.

Neural Stem Cells

9.4.2.2.2.4.

Tissue-Specific Stem Cells

9.4.2.2.3.

Induced Pluripotent Stem Cells

9.4.2.2.3.1.

Reprogramming Factors

9.4.2.2.3.2.

Generation Methods

9.4.2.2.3.3.

Characterization

9.4.2.3.

Stem Cell Niches

9.4.2.3.1.

Niche Components

9.4.2.3.2.

Signaling Pathways

9.4.2.3.3.

Niche Regulation

9.4.3.

Developmental Biology

9.4.3.1.

Embryonic Development

9.4.3.1.1.

9.4.3.1.2.

Cleavage and Blastulation

9.4.3.1.3.

9.4.3.1.4.

9.4.3.2.

Cell Fate Determination

9.4.3.2.1.

Transcription Factors

9.4.3.2.2.

Signaling Pathways

9.4.3.2.3.

Epigenetic Regulation

9.4.3.3.

9.4.3.3.1.

9.4.3.3.2.

9.4.3.3.3.

Tissue Patterning

9.4.4.

Tissue Engineering

9.4.4.1.

Principles of Tissue Engineering

9.4.4.2.

9.4.4.2.1.

Natural Biomaterials

9.4.4.2.2.

Synthetic Biomaterials

9.4.4.2.3.

Biocompatibility

9.4.4.2.4.

Biodegradability

9.4.4.3.

9.4.4.3.1.

Scaffold Design

9.4.4.3.2.

Fabrication Methods

9.4.4.3.3.

Surface Modification

9.4.4.4.

9.4.4.4.1.

9.4.4.4.2.

9.4.4.4.3.

9.4.4.5.

9.4.4.5.1.

9.4.4.5.2.

Dynamic Culture

9.4.4.5.3.

Perfusion Systems

9.4.5.

9.4.5.1.

Cell-Based Therapeutics

9.4.5.2.

Cell Processing

9.4.5.2.1.

9.4.5.2.2.

9.4.5.2.3.

Cell Characterization

9.4.5.2.4.

Quality Control

9.4.5.3.

Delivery Methods

9.4.5.3.1.

9.4.5.3.2.

Systemic Delivery

9.4.5.3.3.

Targeted Delivery

9.4.5.4.

Clinical Applications

9.4.5.4.1.

Hematopoietic Cell Transplantation

9.4.5.4.2.

Cardiac Cell Therapy

9.4.5.4.3.

Neural Cell Therapy

9.4.5.4.4.

Orthopedic Applications

9.4.6.

9.4.6.1.

Gene Delivery Vectors

9.4.6.1.1.

9.4.6.1.2.

Non-Viral Vectors

9.4.6.1.3.

Physical Methods

9.4.6.2.

9.4.6.2.1.

CRISPR-Cas Systems

9.4.6.2.2.

9.4.6.2.3.

9.4.6.3.

Therapeutic Strategies

9.4.6.3.1.

9.4.6.3.2.

Gene Correction

9.4.6.3.3.

9.4.7.

Organ Transplantation

9.4.7.1.

Transplant Immunology

9.4.7.2.

Organ Preservation

9.4.7.3.

Xenotransplantation

9.4.7.4.

Artificial Organs

9.4.8.

Regulatory Considerations

9.4.8.1.

FDA Regulations

9.4.8.2.

Clinical Trial Design

9.4.8.3.

Manufacturing Standards

9.4.8.4.

Ethical Considerations

9.4.9.

Challenges and Future Directions

9.4.9.1.

Technical Challenges

9.4.9.2.

Safety Concerns

9.4.9.3.

Cost Considerations

9.4.9.4.

Personalized Medicine

9.5.

Systems Biology

9.5.1.

Introduction to Systems Biology

9.5.1.1.

Definition and Scope

9.5.1.2.

Systems vs Reductionist Approaches

9.5.1.3.

Emergence and Complexity

9.5.1.4.

Historical Development

9.5.2.

Systems Thinking

9.5.2.1.

Holistic Approach

9.5.2.2.

Network Perspectives

9.5.2.3.

Multi-Scale Analysis

9.5.2.4.

Interdisciplinary Integration

9.5.3.

Biological Networks

9.5.3.1.

Types of Biological Networks

9.5.3.1.1.

Protein-Protein Interaction Networks

9.5.3.1.2.

Gene Regulatory Networks

9.5.3.1.3.

Metabolic Networks

9.5.3.1.4.

Signaling Networks

9.5.3.2.

Network Properties

9.5.3.2.1.

9.5.3.2.2.

9.5.3.2.3.

9.5.3.2.4.

9.5.3.3.

Network Analysis Methods

9.5.3.3.1.

Centrality Measures

9.5.3.3.2.

Clustering Algorithms

9.5.3.3.3.

Pathway Analysis

9.5.3.3.4.

Network Comparison

9.5.4.

Mathematical Modeling

9.5.4.1.

9.5.4.1.1.

Deterministic Models

9.5.4.1.2.

Stochastic Models

9.5.4.1.3.

Discrete Models

9.5.4.1.4.

Continuous Models

9.5.4.2.

Ordinary Differential Equations

9.5.4.2.1.

9.5.4.2.2.

Non-Linear Systems

9.5.4.2.3.

Steady-State Analysis

9.5.4.2.4.

Stability Analysis

9.5.4.3.

Boolean Networks

9.5.4.3.1.

Boolean Functions

9.5.4.3.2.

9.5.4.3.3.

Network Dynamics

9.5.4.4.

Agent-Based Models

9.5.4.4.1.

Individual-Based Modeling

9.5.4.4.2.

Emergent Behavior

9.5.4.4.3.

Multi-Agent Systems

9.5.5.

Omics Integration

9.5.5.1.

Multi-Omics Approaches

9.5.5.1.1.

9.5.5.1.2.

Transcriptomics

9.5.5.1.3.

9.5.5.1.4.

9.5.5.1.5.

9.5.5.2.

Data Integration Methods

9.5.5.2.1.

Statistical Integration

9.5.5.2.2.

Network-Based Integration

9.5.5.2.3.

Machine Learning Approaches

9.5.5.3.

Systems Pharmacology

9.5.5.3.1.

Drug-Target Networks

9.5.5.3.2.

Polypharmacology

9.5.5.3.3.

Drug Repurposing

9.5.6.

Computational Tools

9.5.6.1.

Simulation Software

9.5.6.2.

Network Analysis Tools

9.5.6.3.

Database Resources

9.5.6.4.

Visualization Methods

9.5.7.

Applications in Disease

9.5.7.1.

Cancer Systems Biology

9.5.7.1.1.

Tumor Heterogeneity

9.5.7.1.2.

Drug Resistance

9.5.7.1.3.

Biomarker Discovery

9.5.7.2.

Metabolic Diseases

9.5.7.2.1.

9.5.7.2.2.

9.5.7.2.3.

Metabolic Syndrome

9.5.7.3.

Neurological Disorders

9.5.7.3.1.

Alzheimer's Disease

9.5.7.3.2.

Parkinson's Disease

9.5.7.3.3.

9.5.7.4.

Infectious Diseases

9.5.7.4.1.

Host-Pathogen Interactions

9.5.7.4.2.

Antimicrobial Resistance

9.5.7.4.3.

Vaccine Development

9.5.8.

Personalized Medicine

9.5.8.1.

Individual Variability

9.5.8.2.

Biomarker Identification

9.5.8.3.

Treatment Optimization

9.5.8.4.

Precision Dosing

9.5.9.

Synthetic Biology

9.5.9.1.

Biological Design Principles

9.5.9.2.

Standardized Parts

9.5.9.3.

Genetic Circuits

9.5.9.4.

9.5.9.5.

Therapeutic Applications

9.5.10.

Challenges and Future Directions

9.5.10.1.

Data Quality and Standardization

9.5.10.2.

Model Validation

9.5.10.3.

Computational Complexity

9.5.10.4.

Translation to Clinical Practice

Previous

8. Biomedical Laboratory Disciplines

Go to top

Back to Start

1. Foundations of Biomedical Science